Abstract
Recently, novel approaches to anti-cancer therapy have been described that involve gene transfer. These include anti-angiogenic strategies and vascular targeting of gene therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aird. W.C., Jahroudi, N., Weiler-Guettlen H., Rayburn, H.B., and Rosenberg, R.D. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl. Acad. Sci. USA, 92:4567–4571, 1995.
Borelli. E., Heyman, R., Hsi, M., and Evans, R.M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl Acad. Sci. USA, 85:7572–7576, 1988.
Burrows, F.J. and Thorpe, P.E. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl. Acad. Sci. USA, 90:8996–9000, 1993.
Clarke, M.S.F. and West, D.C. The identification of proliferation and tumor-induced proteins in human endothelial cells: a possible target for tumor therapy. Electrophoresis, 12:500–508, 1991.
Collins. T., Williams, A., Johnson, G.I., Kim, J., Eddy, R., Shows, T., Gimbrone Jr., M.A., and Bevilacqua, D.L. Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol. Chem., 266:2466–2473, 1991.
Denekamp, J. Endothelial cell proliferation as a novel approach to targeting tumor therapy. Br. J. Cancer, 45:136–139,1982.
Denekamp, J. and Hobson. B. Endothelial-cell proliferation in experimental tumors. Br. J. Cancer, 46:711–720, 1982.
Hurford Jr., R.K., Dranoff G., Mulligan, R.C., and Tepper, R.I. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat. Genet., 10:430–435, 1995.
Lienard, D., Ewalenko, P., Delmotte, J.J., Renard, N., and Lejeune, F.J. High dose recombinant tumor necrosis factor a in combination with interferon γ and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol., 10:52–60, 1992.
Millauer, B., Shawver, L.K., Plate, K.H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature, 367:576–579, 1994.
Millauer, B., Longhi, M.P., Plate, K.H., Shawver, L.K., Risau, W., Ullrich, A., and Strawn, L.M. Dominant-negative inhibition of flk-1 suppresses the growth of many tumor types in vivo. Cancer Res., 56:1615–1620,1996.
Miller, A.D., and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol, 6:2895–2902, 1986.
Montgomery, K.F., Osborn L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P.I., Bomsztyk, K., Lobb, R., Harlan, J.M., and Pohlman, T.H. Activation of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA, 88:6523–6527, 1991.
Mullen, C.A., Kilstrup, M., and Blaese, R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine — a negative selection system. Proc. Natl Acad. Sci. USA, 89:33–37, 1992.
Patterson, A.V., Zhang, H-T., Moghaddam, A., Bicknell, R., Talbot, D.C., Stratford, I.J., and Harris, A.L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer, 72:669–675, 1995a.
Patterson, C., Perrella, M.A., Hsieh, C-M., Yoshizumi, M., Lee, M-E., and Haber, E. Cloning and functional analysis of the promoter for KDR/flk-1: a receptor for vascular endothelial growth factor. J. Biol. Chem., 270:23111–23124, 1995b.
Russell, D.W., Berger, M.S., and Miller, A.D. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum. Gen. Ther., 6:635–641, 1995.
Sato, N., Goto, T., Haranaka, K., Satomi, N., Nariuchi, H., Mano-Hirano, Y., and Sawasaki, Y. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. Natl Cancer Inst., 76:1113–1121, 1986.
Schweigerer, L., Malerstein, B., and Gospodarowicz, D. Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem. Biophys Res. Comm., 143:997–1004, 1987.
Welsh, R.M., Jensen, F.C., Cooper, N.R., and Oldstone, M.B.A. Inactivation of lysis of oncornaviruses by human serum. Virology, 74:432–440, 1975.
Yu, S.-F., Rueden, T., Kantoff, P.W., Garber, C., Seiberg, M., Ruether, U., Anderson, W.F., Wagner, E.F., and Gilboa, E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA, 83:3194–3198, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jaggar, R.T., Chan, HY., Harris, A.L., Bicknell, R. (1998). Gene Mediated Anti-Cancer Strategies Involving the Vasculature. In: Catravas, J.D., Callow, A.D., Ryan, U.S. (eds) Vascular Endothelium. NATO ASI Series, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0133-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0133-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0135-4
Online ISBN: 978-1-4899-0133-0
eBook Packages: Springer Book Archive